Clinical study - Pédiatrie Tumeurs solides

TEMOKIDS
Pédiatrie Tumeurs solides
Ouvert depuis le: 09.20.2021
Site: Paris
Public cible
Enfant
TEMOkids Study: A Population Pharmacokinetic, Acceptability and Safety Study for KIMOZO, a Paediatric Oral Suspension of Temozolomide
Description de l'essai

Non-randomized, international, multi-centre, open-label, single arm study to determine the pharmacokinetic (PK) parameters of a single dose of an oral suspension of temozolomide (KIMOZO) in the pediatric population aged 1 year and over.